Advertisement
Advertisement
GEHC
GE HealthCare Technologies Inc. Common Stock
83.51
USDSponsored
-0.52
-0.61%
Nov 10, 14:10 UTC -5
Open
GE HealthCare Technologies Inc. Common Stock (GEHC) Earnings
GEHC Earnings Reports
Positive Surprise Ratio
GEHC beat 12 of 15 last estimates.
80%
Next Report
Date of Next Report
Feb 08, 2027
Estimate for Q4 26 (Revenue/ EPS)
$6.04B
/$1.58
Implied change from Q3 26 (Revenue/ EPS)
+9.61%
/+17.91%
Implied change from Q4 25 (Revenue/ EPS)
+6.05%
/+9.72%
GE HealthCare Technologies Inc. Common Stock earnings per share and revenue
On Oct 28, 2026, GEHC reported earnings of 1.34 USD per share (EPS) for Q3 26, beating the estimate of 1.22 USD, resulting in a 9.13% surprise. Revenue reached 5.51 billion, compared to an expected 5.46 billion, with a 1.02% difference. The market reacted with a +6.62% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 1.58 USD, with revenue projected to reach 6.04 billion USD, implying an increase of 17.91% EPS, and increase of 9.61% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Village Farms International, Inc. Common Shares
Report Date
Nov 09, 2026 For Q3 26
Estimate
$0.05
Actual
$0.08
Surprise
+48.42%
Aurora Cannabis Inc. Common Shares
Report Date
Nov 05, 2026 For Q2 27
Estimate
-$0.08
Actual
-$0.32
Surprise
-261.99%
Canopy Growth Corporation Common Shares
Report Date
Nov 06, 2026 For Q2 27
Estimate
-$0.03
Actual
-$0.01
Surprise
+71.75%
InfuSystem Holdings, Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.13
Actual
$0.15
Surprise
+13.12%
OraSure Technologies Inc
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.20
Actual
-$0.15
Surprise
+28.26%
TriSalus Life Sciences, Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.15
Surprise
-14.85%
Exagen Inc. Common Stock
Report Date
Nov 10, 2026 For Q3 26
Estimate
-$0.18
Actual
-$0.25
Surprise
-35.35%
Quanterix Corporation Common Stock
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.44
Actual
-$0.46
Surprise
-3.67%
Myomo Inc.
Report Date
Nov 09, 2026 For Q3 26
Estimate
-$0.07
Actual
-$0.07
Surprise
+11.17%
Nephros Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.02
Actual
$0.05
Surprise
+110.08%
FAQ
What were GE HealthCare Technologies Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, GE HealthCare Technologies Inc. Common Stock reported EPS of $1.34, beating estimates by 9.13%, and revenue of $5.51B, 1.02% above expectations.
How did the market react to GE HealthCare Technologies Inc. Common Stock's Q3 2026 earnings?
The stock price moved up 6.62%, changed from $71.11 before the earnings release to $75.82 the day after.
When is GE HealthCare Technologies Inc. Common Stock expected to report next?
The next earning report is scheduled for Feb 08, 2027.
What are the forecasts for GE HealthCare Technologies Inc. Common Stock's next earnings report?
Based on --
analysts, GE HealthCare Technologies Inc. Common Stock is expected to report EPS of $1.58 and revenue of $6.04B for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.